Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Franz B. Humer currently holds 95,400 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Franz B. Humer has been a net buyer of ALLO stock. They have purchased $540.0K and sold $26.2K worth of shares.
Franz B. Humer's most recent insider trade was on Jun 18, 2026, when they sold 95,400 shares at $0.00 per share.
Franz B. Humer serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 73 insider transactions totaling $566.2K over their tenure at the company.
Franz B. Humer holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Franz B. Humer has shown a buying trading pattern, with $540.0K in total purchases and $26.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Franz B. Humer was on Oct 3, 2017, when they sold $832.3K worth of KITE shares. This transaction involved 4,624 shares at $180.00 per share.
Franz B. Humer currently owns 95,400 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Franz B. Humer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Franz B. Humer has 73 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Franz B. Humer and 40,000+ other insiders.